CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib - Concepedia

Concepedia

Publication | Open Access

CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor: A Phase I Study of Vimseltinib

DOI Full Paper Access

22

Citations

18

References

2024

Year

Hans Gelderblom, Albiruni Abdul Razak, Matthew H. Taylor, Todd M. Bauer, Breelyn A. Wilky, Javier Martín‐Broto, Piotr Rutkowski, Bartłomiej Szostakowski, Thierry Alcindor, Ramy Saleh,

Clinical Cancer Research

Abstract

Vimseltinib demonstrated long-term tolerability, manageable safety, dose-dependent exposure, and robust antitumor activity in patients with TGCT not amenable to surgery.

References

	Year	Citations

Page 1